Biotech
An Exeter-based biotech company has partnered with L'Oréal to explore new ways of reversing the ageing process at the cellular level. SENISCA, a spinout from the University of Exeter, will collaborate with L'Oréal under a newly announced research agreement targeting senescent cells — older cells that no longer function properly but remain active in the [...]
Odgers’ Chris Hamilton and Mike Drew examine how high-profile investment is reshaping executive leadership in longevity tech. The longevity tech sector was once a quiet corner of academic research. Now it has rapidly become one of the most exciting frontiers in innovation. Driven by soaring investment from billionaires and mission-led funds, the industry is redefining [...]
Artificial intelligence firm SandboxAQ has released a dataset designed to help researchers predict drug-protein binding, a key step in early drug development. The company generated approximately 5.2 million synthetic 3D molecules using Nvidia chips, instead of through traditional laboratory experiments. The dataset, released on Wednesday, is intended to support the development of faster drug screening [...]
Superlab Suisse has announced the opening of its fourth Swiss laboratory facility at Campus Biotech in Geneva, which will be ready for move-in by January 2026. The new location will offer fully serviced laboratory space for biotech startups and life science companies in the Lake Geneva region. This expansion completes Superlab Suisse’s national footprint, adding to [...]
Odgers’ Chris Hamilton and Mike Drew explain why the success of precision medicine will hinge on the development of critical leadership roles Precision medicine stands at the forefront of a transformative era in healthcare. As technological advancements in AI, genomics, and data analytics converge, the market for precision medicine is poised for exponential growth. By [...]
A major UK clinical trial has found that combining two targeted drugs leads to better survival and fewer side effects than chemotherapy for people with chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults. The Flair trial involved 786 people with previously untreated CLL, treated across 96 cancer centres in the UK. [...]
Mosanna Therapeutics has secured US$80m in Series A funding to advance development of a nasal spray for obstructive sleep apnoea (OSA), a condition where breathing stops and starts during sleep due to a blocked airway. The investment will support Phase II trials of MOS118, a spray used at night which aims to restore natural airway [...]
The UK has launched an £8m initiative to create what is claimed will be the world’s largest dataset of drug-protein binding data, as part of wider efforts to speed up AI-driven medicine development. The OpenBind consortium, based at the Diamond Light Source in Oxfordshire, aims to generate more than 500,000 experimentally validated protein-ligand structures and [...]
Researchers have found a way to flush out hidden HIV in human cells, potentially bringing scientists a step closer to a cure. The breakthrough uses mRNA technology to expose the virus inside white blood cells, where it normally escapes detection by both the immune system and current treatments. The team developed a new delivery method [...]
Health Tech World explores the latest research and developments in health technology. Scientists develop a method for engineering ultra-selective aptamers Inspired by the way viruses attach to cells, EPFL scientists have developed a method for engineering ultra-selective aptamers - short segments of DNA or RNA that are designed to bind, like antibodies, to specific targets, [...]
